Interobserver agreement for estrogen receptor immunohistochemical analysis in breast cancer: a comparison of manual and computer-assisted scoring methods.
暂无分享,去创建一个
[1] B. Fisher,et al. Tamoxifen with and without radiation after partial mastectomy in patients with involved nodes. , 1995, International journal of radiation oncology, biology, physics.
[2] R. Gelber,et al. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. , 1995, Journal of the National Cancer Institute.
[3] P. Bendahl,et al. Estrogen and Progesterone Receptor Assay in Paraffin-Embedded Breast Cancer , 2003, Acta oncologica.
[4] L. Layfield,et al. Tissue heterogeneity of immunohistochemically detected estrogen receptor. Implications for image analysis quantification. , 1998, American journal of clinical pathology.
[5] B. Fisher,et al. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence. , 1998, International journal of radiation oncology, biology, physics.
[6] S. Martino,et al. Estrogen receptor (ER) and progesterone receptor (PgR), by ligand‐binding assay compared with ER, PgR and pS2, by immuno‐histochemistry in predicting response to tamoxifen in metastatic breast cancer: A Southwest Oncology Group study , 2000, International journal of cancer.
[7] L. Layfield,et al. Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early‐stage breast carcinomas: Prognostic significance , 1996, Journal of surgical oncology.
[8] F Breitenecker,et al. Modified true-color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: a comparison. , 1999, Anticancer research.
[9] B. Angus,et al. New monoclonal antibodies to oestrogen and progesterone receptors effective for paraffin section immunohistochemistry , 1997, The Journal of pathology.
[10] W. Bezwoda,et al. The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates with response to tamoxifen , 1991, Cancer.
[11] S. Bacus,et al. Quantification of estrogen receptors on paraffin-embedded tumors by image analysis. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[12] J. Jacquemier,et al. Estrogen receptor immunocytochemical assay (ER-ICA): computerized image analysis system, immunoelectron microscopy, and comparisons with estradiol binding assays in 115 breast carcinomas. , 1986, Cancer research.
[13] J M Esteban,et al. Quantitative immunohistochemical assay for hormonal receptors: technical aspects and biological significance. , 1994, Journal of cellular biochemistry. Supplement.
[14] S. Edge,et al. Prognostic factors in breast cancer , 2005 .
[15] C K Osborne,et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] L. Layfield,et al. Assessment of Tissue Estrogen and Progesterone Receptor Levels: A Survey of Current Practice, Techniques, and Quantitation Methods , 2000, The breast journal.
[17] R. Gelber,et al. Meeting highlights: international consensus panel on the treatment of primary breast cancer. , 2002, Journal of the National Cancer Institute.
[18] H. Frierson,et al. Automated immunohistochemical assay for estrogen receptor status in breast cancer using monoclonal antibody CC4-5 on the Ventana ES. , 1996, American journal of clinical pathology.
[19] J. Feldman,et al. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Spγ in frozen sections or cytosol‐based ligand‐binding assays , 1996, Cancer.
[20] R. Gelber,et al. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] M. Duffy,et al. Objective measurement of breast cancer oestrogen receptor status through digital image analysis. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[22] S. Swain. Tamoxifen for patients with estrogen receptor-negative breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] K Vajda,et al. [Prognostic factors in breast cancer]. , 1998, Orvosi hetilap.